Propranolol or propranolol combined endoscopic treatments for secondary prophylaxis of esophageal variceal bleeding: a comparison study
10.3760/cma.j.issn.1007-5232.2011.06.004
- VernacularTitle:心得安单纯或联合使用在二级预防食管静脉曲张出血中的疗效比较
- Author:
Wenfang CHENG
;
Tingsheng LING
;
Ruihua SHI
;
Xiaoxing CHEN
;
Jing DING
;
Li CHEN
- Publication Type:Journal Article
- Keywords:
Esophageal and gastric varices;
Propranolol;
Endoscopic variceal ligation;
Endoscopic variceal sclerotherapy;
Secondary prophylaxis
- From:
Chinese Journal of Digestive Endoscopy
2011;28(6):313-315
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the prophylactic effects of propranolol, propranolol plus endoscopic variceal ligation (EVL) and propranolol plus endoscopic sclerotherapy (EVS), and to determine the most effective combination for secondary prevention of esophageal variceal bleeding.Methods After hemostasis, a total of 78 patients with esophageal variceal bleeding were randomly assigned to receive propranolol (propranolol group), propranolol plus EVL (ligation group) or propranolol plus sclerotherapy (EVS group), with 26 in each group.All patients were followed up for 12 months, and the rates of variceal re-bleeding, mortality, portal hypertensive gastropathy (PHG), re-occurrence of esophageal varices and formation of gastric fundus varices were compared among different groups.Results During the 12-month follow-up, the rate of re-bleeding in EVL group (30.77%) was significantly lower than those of the EVS group (42.31%) or propranolol group (53.85%) (P<0.05).The occurrence of PHG and fundal varices in patients of EVL group was similar to that of propranolol group, which were both lower than that of EVS group (P<0.05), but the re-occurrence of esophageal varices in EVL group was significantly higher than that of EVS group (P<0.05).Conclusion EVL plus propranolol might be the most effective therapy for secondary prophylaxis of esophageal variceal bleeding.
